Drug Database
Back to search

Poland· PL-100189773

Eligard 45 mg

A leuprorelin product containing leuprorelinum, registered in Poland by Recordati Industria Chimica e Farmaceutica S.p.A. The same ATC class is registered in 13 of our 19 countries.

ATC L02AE02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEligard 45 mgATCL02AE02REGISTER NO.PL-100189773PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about leuprorelinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Leuprorelin is registered in 13 of 19 countries.

Countries holding a registration under ATC L02AE02 (leuprorelin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search leuprorelin products by name

Leuprorelin · ATC L02AE02

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of leuprorelin costs, country by country.

Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Leuprorelin · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$34.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Leuprorelinum
Manufacturer
Recordati Industria Chimica e Farmaceutica S.p.A
Country
Poland (PL)
ATC code
L02AE02
ATC class
Leuprorelin
Defined daily dose
1 mg, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

1 priced
  • gtin
    05909990634057
    1 zest. (2 strz.napeł.)
    PLN 1234.32
  • gtin
    05909990634040

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

320 interactions on record for leuprorelin.

Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check leuprorelin against other medicinesHow interaction checks work

Leuprorelin · interactions on record

320 records

  • 69 severe
  • 248 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Leuprorelin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All leuprorelin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Eligard Depot, Enantone Monats-Depot
  • Belgium · Depo-Eligard
  • Bulgaria · Елигард, Лутрат Депо
  • Cyprus · Eligard
  • Czechia · Eligard, Leptoprol
  • Germany · Eligard, Enantone Monats-Depot
  • Denmark · Eligard, Leuprorelin Sandoz
  • Estonia · Eligard
  • Spain · Eligard Semestral, Eligard Trimestral
  • Finland · Eligard, Enanton Depot Dual
  • France · Eligard, Enantone Lp
  • United Kingdom (Northern Ireland) · Prostap 3 Dcs, Prostap Pd Dcs
  • Greece · Deplanda, Elityran
  • Croatia · Eligard, Lerin
  • Hungary · Eligard, Leuprorelin Pharmacenter
  • Ireland · Eligard, Leuprex 3
  • Iceland · Camcevi, Eligard
  • Italy · Eligard, Enantone
  • Liechtenstein · Camcevi
  • Lithuania · Eligard
  • Luxembourg · Depo-Eligard, Leugon
  • Latvia · Eligard, Leptoprol
  • Malta · Deplanda
  • Netherlands · Eligard, Leuproreline Sandoz
  • Norway · Camcevi, Eligard
  • Portugal · Eligard, Lutrate Depot
  • Romania · Eligard, Leptoprol
  • Sweden · Eligard, Enanton Depot Dual
  • Slovenia · Eligard, Leptoprol
  • Slovakia · Eligard, Leuprorelin Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/627dffb1-aac0-4869-ac90-6e68860c1c65
GET /v1/drugs/627dffb1-aac0-4869-ac90-6e68860c1c65?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
  "source": "urpl",
  "strength": "45 mg",
  "packaging": "05909990634040 ¦ Rp ¦ Skasowane ¦ 42086\n1 zestaw \n05909990634057 ¦ Rp ¦ 42094\n1 amp.-strzyk. 45 mg proszek ¦ 1 amp.-strzyk.  rozpuszczalnik",
  "substance": "Leuprorelini acetas 45 mg",
  "common_name": "Leuprorelinum",
  "pl_product_id": "100189773",
  "pozwolenie_nr": "14300",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about leuprorelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console